Literature DB >> 19700140

A synthetic non-degradable polyethylene glycol hydrogel retards adverse post-infarct left ventricular remodeling.

Stephan Dobner1, Deon Bezuidenhout, Padmini Govender, Peter Zilla, Neil Davies.   

Abstract

BACKGROUND: Left ventricular remodeling after myocardial infarction is a key component of heart failure and it has long been postulated that it may result from increased wall stress. It has recently been suggested that an injectable, non-degradable polymer may limit pathological remodeling in a manner analogous to that of cardiac support devices. We have tested a non-degradable polyethylene glycol (PEG) gel in a rat infarction model. METHODS AND
RESULTS: After permanent ligation of the left anterior descending artery in male Wistar rats, PEG gel reagents were injected into the infarcted region and polymerized in situ. At 4 weeks, fractional shortening and infarct volume were unchanged relative to a saline injected control, but the infarct-induced left ventricular end-diastolic diameter (LVEDD) increase was substantially reduced (43%, P < .05) and wall thinning was completely prevented. At 13 weeks, the LVEDD were similar for both saline- and PEG-injected hearts. The non-degradable PEG gels did elicit a macrophage-based inflammatory reaction.
CONCLUSIONS: The injection of non-degradable synthetic gel was effective in ameliorating pathological remodeling in the immediate postinfarction healing phase, but was unable to prevent the dilation that occurred at later stages in the healed heart.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19700140     DOI: 10.1016/j.cardfail.2009.03.003

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  43 in total

1.  Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model.

Authors:  Jamie L Ifkovits; Elena Tous; Masahito Minakawa; Masato Morita; J Daniel Robb; Kevin J Koomalsingh; Joseph H Gorman; Robert C Gorman; Jason A Burdick
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction.

Authors:  Hassan K Awada; Noah R Johnson; Yadong Wang
Journal:  J Control Release       Date:  2015-03-31       Impact factor: 9.776

3.  Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering.

Authors:  Sonya B Seif-Naraghi; Michael A Salvatore; Pam J Schup-Magoffin; Diane P Hu; Karen L Christman
Journal:  Tissue Eng Part A       Date:  2010-06       Impact factor: 3.845

Review 4.  Injectable acellular hydrogels for cardiac repair.

Authors:  Elena Tous; Brendan Purcell; Jamie L Ifkovits; Jason A Burdick
Journal:  J Cardiovasc Transl Res       Date:  2011-06-28       Impact factor: 4.132

5.  In vitro comparative study of two decellularization protocols in search of an optimal myocardial scaffold for recellularization.

Authors:  Isaac Perea-Gil; Juan J Uriarte; Cristina Prat-Vidal; Carolina Gálvez-Montón; Santiago Roura; Aida Llucià-Valldeperas; Carolina Soler-Botija; Ramon Farré; Daniel Navajas; Antoni Bayes-Genis
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

6.  A degradable, bioactive, gelatinized alginate hydrogel to improve stem cell/growth factor delivery and facilitate healing after myocardial infarction.

Authors:  Domenico G Della Rocca; Bradley J Willenberg; Leonardo F Ferreira; Prateek S Wate; John W Petersen; Eileen M Handberg; Tong Zheng; Dennis A Steindler; Naohiro Terada; Christopher D Batich; Barry J Byrne; Carl J Pepine
Journal:  Med Hypotheses       Date:  2012-08-28       Impact factor: 1.538

7.  Effect of intra-myocardial Algisyl-LVR™ injectates on fibre structure in porcine heart failure.

Authors:  K L Sack; E Aliotta; J S Choy; D B Ennis; N H Davies; T Franz; G S Kassab; J M Guccione
Journal:  J Mech Behav Biomed Mater       Date:  2018-07-10

8.  Oxime cross-linked injectable hydrogels for catheter delivery.

Authors:  Gregory N Grover; Rebecca L Braden; Karen L Christman
Journal:  Adv Mater       Date:  2013-03-12       Impact factor: 30.849

9.  MRI evaluation of injectable hyaluronic acid-based hydrogel therapy to limit ventricular remodeling after myocardial infarction.

Authors:  Shauna M Dorsey; Jeremy R McGarvey; Hua Wang; Amir Nikou; Leron Arama; Kevin J Koomalsingh; Norihiro Kondo; Joseph H Gorman; James J Pilla; Robert C Gorman; Jonathan F Wenk; Jason A Burdick
Journal:  Biomaterials       Date:  2015-08-06       Impact factor: 12.479

Review 10.  Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices.

Authors:  Jennifer M Singelyn; Karen L Christman
Journal:  J Cardiovasc Transl Res       Date:  2010-07-15       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.